Logo image of MRX.DE

MISTER SPEX SE (MRX.DE) Stock Fundamental Analysis

FRA:MRX - Deutsche Boerse Ag - DE000A3CSAE2 - Common Stock - Currency: EUR

1.5  0 (0%)

Fundamental Rating

2

Taking everything into account, MRX scores 2 out of 10 in our fundamental rating. MRX was compared to 54 industry peers in the Specialty Retail industry. MRX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, MRX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MRX has reported negative net income.
In the past year MRX has reported a negative cash flow from operations.
In the past 5 years MRX always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: MRX reported negative operating cash flow in multiple years.
MRX.DE Yearly Net Income VS EBIT VS OCF VS FCFMRX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 -10M -20M -30M -40M

1.2 Ratios

MRX has a Return On Assets of -23.46%. This is amonst the worse of the industry: MRX underperforms 85.19% of its industry peers.
MRX has a Return On Equity of -44.25%. This is amonst the worse of the industry: MRX underperforms 81.48% of its industry peers.
Industry RankSector Rank
ROA -23.46%
ROE -44.25%
ROIC N/A
ROA(3y)-14.03%
ROA(5y)-11.64%
ROE(3y)-22.01%
ROE(5y)-25.74%
ROIC(3y)N/A
ROIC(5y)N/A
MRX.DE Yearly ROA, ROE, ROICMRX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60 -80

1.3 Margins

With a decent Gross Margin value of 52.57%, MRX is doing good in the industry, outperforming 77.78% of the companies in the same industry.
In the last couple of years the Gross Margin of MRX has grown nicely.
The Profit Margin and Operating Margin are not available for MRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.45%
GM growth 5Y1.76%
MRX.DE Yearly Profit, Operating, Gross MarginsMRX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

MRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
MRX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MRX has more shares outstanding
The debt/assets ratio for MRX is higher compared to a year ago.
MRX.DE Yearly Shares OutstandingMRX.DE Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
MRX.DE Yearly Total Debt VS Total AssetsMRX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -0.52, we must say that MRX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.52, MRX is doing worse than 72.22% of the companies in the same industry.
A Debt/Equity ratio of 0.49 indicates that MRX is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.49, MRX perfoms like the industry average, outperforming 57.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Altman-Z -0.52
ROIC/WACCN/A
WACC5.16%
MRX.DE Yearly LT Debt VS Equity VS FCFMRX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 3.04 indicates that MRX has no problem at all paying its short term obligations.
MRX has a Current ratio of 3.04. This is amongst the best in the industry. MRX outperforms 90.74% of its industry peers.
MRX has a Quick Ratio of 2.24. This indicates that MRX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.24, MRX belongs to the best of the industry, outperforming 90.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.04
Quick Ratio 2.24
MRX.DE Yearly Current Assets VS Current LiabilitesMRX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

4

3. Growth

3.1 Past

MRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.77%.
MRX shows a small growth in Revenue. In the last year, the Revenue has grown by 1.30%.
Measured over the past years, MRX shows a quite strong growth in Revenue. The Revenue has been growing by 12.73% on average per year.
EPS 1Y (TTM)-20.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-67.86%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y10.83%
Revenue growth 5Y12.73%
Sales Q2Q%-3.17%

3.2 Future

Based on estimates for the next years, MRX will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.00% on average per year.
MRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.66% yearly.
EPS Next Y-86.57%
EPS Next 2Y2.85%
EPS Next 3Y13.18%
EPS Next 5Y14%
Revenue Next Year-2.59%
Revenue Next 2Y-5.08%
Revenue Next 3Y-2.37%
Revenue Next 5Y8.66%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MRX.DE Yearly Revenue VS EstimatesMRX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
MRX.DE Yearly EPS VS EstimatesMRX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MRX. In the last year negative earnings were reported.
Also next year MRX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MRX.DE Price Earnings VS Forward Price EarningsMRX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MRX.DE Per share dataMRX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as MRX's earnings are expected to grow with 13.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.85%
EPS Next 3Y13.18%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MRX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MISTER SPEX SE

FRA:MRX (5/27/2025, 7:00:00 PM)

1.5

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-08 2024-05-08/amc
Earnings (Next)N/A N/A
Inst Owners25.4%
Inst Owner ChangeN/A
Ins Owners3.98%
Ins Owner ChangeN/A
Market Cap52.58M
Analysts77.5
Price Target4.23 (182%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-14.21%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B 0.42
P/tB 0.53
EV/EBITDA N/A
EPS(TTM)-1.65
EYN/A
EPS(NY)-0.77
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.38
OCFYN/A
SpS6.37
BVpS3.56
TBVpS2.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.46%
ROE -44.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.57%
FCFM N/A
ROA(3y)-14.03%
ROA(5y)-11.64%
ROE(3y)-22.01%
ROE(5y)-25.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.45%
GM growth 5Y1.76%
F-Score4
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.75%
Cap/Sales 3.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.04
Quick Ratio 2.24
Altman-Z -0.52
F-Score4
WACC5.16%
ROIC/WACCN/A
Cap/Depr(3y)72.39%
Cap/Depr(5y)88.93%
Cap/Sales(3y)8.02%
Cap/Sales(5y)7.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-67.86%
EPS Next Y-86.57%
EPS Next 2Y2.85%
EPS Next 3Y13.18%
EPS Next 5Y14%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y10.83%
Revenue growth 5Y12.73%
Sales Q2Q%-3.17%
Revenue Next Year-2.59%
Revenue Next 2Y-5.08%
Revenue Next 3Y-2.37%
Revenue Next 5Y8.66%
EBIT growth 1Y-25.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year75.11%
EBIT Next 3Y32.33%
EBIT Next 5Y28.78%
FCF growth 1Y48.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y42.05%
OCF growth 3YN/A
OCF growth 5YN/A